Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-27

Clinical Trial Update: Effects of Terlipressin on Blood Loss and Transfusion Requirements During Major Liver Resection. [Phase 2]

View source ↗

Summary

Phase 2 trial assessing terlipressin's effect on blood loss and transfusion needs during major liver resection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Terlipressin (terlipressin)

Snippet

Sponsor: Assiut University | Conditions: Hepatectomy, Surgical Blood Loss, Terlipressin | Phase 2 | Status: COMPLETED